News
The FDA approved dihydroergotamine (DHE) mesylate injection (Brekiya) to treat acute migraine (with or without aura) and ...
Pharmaceutical Technology on MSN19h
FDA approves Amneal’s DHE migraine/cluster headache autoinjectorThis makes Brekiya the first DHE autoinjector for treating these conditions. The autoinjector offers potential pain relief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback